June 26, 2014

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Living Well
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

EastGate Acquisitions Receives Research Grant from Ontario Brain Institute

Press Release

June 26, 2014

Salt Lake City – EastGate Acquisitions Corporation, a pharmaceutical company, announced it has received a research grant from the Ontario Brain Institute for its Lorazepam Spray development.  

The grant was issued for the purpose to study the administration of a transmucosal Lorazepam Spray for the treatment of epileptic seizures in outpatient settings.  The company has entered into a collaboration with a leading neurologist, Dr. Peter Carlen, at the Toronto Western Hospital who will serve as a principal investigator on this trial. 

The intraoral Lorazepam Spray is a new transmucosal non-invasive solution for the treatment of acute and repetitive seizures.  The primary goal of this project is to provide a safe and effective anti-seizure medication to a patient to stop seizures in the shortest period of time.  In addition to being self-administered, an oral administration provides the flexibility to any available person on the scene, be it family members, caregivers or paramedics.  Another key benefit of the Lorazepam Spray is that it can be used at any point during a seizure, even if the patient's mouth is clenched shut as it can be applied directly to the gum or lip mucosa. 

"We are excited about this development as the Ontario Brain Institute grant serves as a significant jump-start for the company's overall financing plans for the technology's platform," said Anna Gluskin, CEO of EastGate Acquisitions Corporation.  "Our innovative technology platform based on a self-nanoemulsion formulation will directly address patient needs for fast onset of treatment and encourage self-administration with the goal of minimizing hospital care and have a positive impact on massive health care costs facing today's healthcare system.”

Utah Business Social
UB Events View All
Forty Under 40Utah Business Event
Feb 26, 2015
Utah Business magazine along with presenting sponsors, Kirton McConkie, Big-D Construction and M...
CEO of the YearUtah Business Event
Mar 20, 2015
Utah Business Magazine and Presenting Sponsors: Holland & Hart and Newmark Grubb ACRES - would li...
2015 Job SummitUtah Business Event
Apr 10, 2015
Position your company as a Premier Employer in today's competitive job market! Utah Business maga...
Community Events View All
UTC Breakfast with Legislative Leadership
Feb 26, 2015
Please join us as we hear from legislative leaders, House Speaker Greg Hughes and Senate Presiden...
Mac OS X Support Essentials
Feb 27, 2015
Using Apple Certified Curriculum, Mac OS X Support Essentials is a hands-on course that provides ...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel